- Public Comps
- Kolmar Korea
Kolmar Korea Valuation Multiples
Discover Kolmar Korea's revenue and EBITDA valuation multiples and investment history, alongside public comparables like Qingdao Baheal Medical, Harbin Fuerjia Technology, SILICON2, Honasa Consumer and more.
Kolmar Korea Overview
About Kolmar Korea
Kolmar Korea Co Ltd is a Korea-based company which is mainly engaged in manufacture and sale of cosmetics. It offers various products such as skin care, makeup, hair care, body care and others. The firm is also involved in development and production of pharmaceutical products and quasi-drugs including general medicines, specialized medicines, bioequivalence medicines and others.
Founded
2012
HQ

Employees
N/A
Website
Sectors
Financials (LTM)
EV
$2.4B
Valuation Multiples
Start free trialKolmar Korea Financials
Kolmar Korea reported last 12-month revenue of $2B and EBITDA of $263M.
In the same LTM period, Kolmar Korea generated $577M in gross profit, $263M in EBITDA, and $101M in net income.
Revenue (LTM)
Kolmar Korea P&L
In the most recent fiscal year, Kolmar Korea reported revenue of $1.9B and EBITDA of $239M.
Kolmar Korea is profitable as of last fiscal year, with gross margin of 28%, EBITDA margin of 13%, and net margin of 5%.
Financial data powered by Morningstar, Inc.
Kolmar Korea Stock Performance
Kolmar Korea has current market cap of $1.7B, and enterprise value of $2.4B.
Market Cap Evolution
Kolmar Korea's stock price is $72.38.
Kolmar Korea share price increased by 12.1% in the last 30 days, and by 10.2% in the last year.
Kolmar Korea has an EPS (earnings per share) of $3.70.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2.4B | $1.7B | -0.5% | 12.1% | 21.4% | 10.2% | $3.70 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialKolmar Korea Valuation Multiples
Kolmar Korea trades at 1.2x EV/Revenue multiple, and 9.0x EV/EBITDA.
EV / Revenue (LTM)
Kolmar Korea Financial Valuation Multiples
As of July 19, 2026, Kolmar Korea has market cap of $1.7B and EV of $2.4B.
Kolmar Korea has a P/E ratio of 16.8x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Kolmar Korea Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Kolmar Korea Margins & Growth Rates
Kolmar Korea grew revenue by 9% and EBITDA by 19% in the last fiscal year.
In the most recent fiscal year, Kolmar Korea reported gross margin of 28%, EBITDA margin of 13%, and net margin of 5%.
Kolmar Korea Margins
Kolmar Korea Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Kolmar Korea Operational KPIs
Kolmar Korea's Rule of 40 is 27% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Kolmar Korea's Rule of X is 46% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Kolmar Korea Competitors
Kolmar Korea competitors include Qingdao Baheal Medical, Harbin Fuerjia Technology, SILICON2, Honasa Consumer, Emami, Faes Farma, Perrigo, Zydus Wellness, Flyco and Botanee Group.
Most Kolmar Korea public comparables operate across Health & Beauty.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.7x | 1.7x | 13.5x | 14.5x | |||
| 5.6x | 4.9x | 16.3x | 15.4x | |||
| 1.9x | 1.6x | 9.6x | 8.7x | |||
| 6.2x | 5.8x | 47.2x | 57.3x | |||
| 4.5x | 4.4x | 16.5x | 17.0x | |||
| 2.6x | 2.4x | 13.6x | 12.0x | |||
| 1.1x | 1.1x | 6.6x | 7.1x | |||
| 5.5x | 5.0x | 42.5x | 36.5x | |||
This data is available for Pro users. Sign up to see all Kolmar Korea competitors and their valuation data. Start Free Trial | ||||||
Investments by Kolmar Korea
Kolmar Korea has invested in 1 company to date.
Latest investment by Kolmar Korea was on June 17th 2026. Kolmar Korea invested in The SMC Group in their $13M Undisclosed stage round (EV/Revenue multiple available to Pro users).
Latest Investments by Kolmar Korea
| Description | The SMC Group is a social marketing agency based in South Korea, specializing in campaign strategy, content creation, and performance analytics for brands on platforms like Instagram, KakaoTalk, and Naver. It delivers targeted advertising, influencer partnerships, and community management to drive engagement and sales in the Korean market. Serving consumer goods, fashion, and tech clients, the Seoul-based firm leverages local trends and data insights for viral social media activations and e-commerce integrations. |
| HQ Country | |
| HQ City | Seoul |
| Deal Date | 17 Jun 2026 |
| Round | Undisclosed stage |
| Raised | $13M |
| Investors | Timepolio Asset Management; Kolmar Korea; LB Investment; Kolon Investment |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Kolmar Korea investments and their VC round multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Kolmar Korea
| When was Kolmar Korea founded? | Kolmar Korea was founded in 2012. |
| Where is Kolmar Korea headquartered? | Kolmar Korea is headquartered in South Korea. |
| Is Kolmar Korea publicly listed? | Yes, Kolmar Korea is a public company listed on Korea Exchange. |
| What is the stock symbol of Kolmar Korea? | Kolmar Korea trades under 161890 ticker. |
| When did Kolmar Korea go public? | Kolmar Korea went public in 2012. |
| Who are competitors of Kolmar Korea? | Kolmar Korea main competitors include Qingdao Baheal Medical, Harbin Fuerjia Technology, SILICON2, Honasa Consumer, Emami, Faes Farma, Perrigo, Zydus Wellness, Flyco, Botanee Group. |
| What is the current market cap of Kolmar Korea? | Kolmar Korea's current market cap is $1.7B. |
| What is the current revenue of Kolmar Korea? | Kolmar Korea's last 12 months revenue is $2B. |
| What is the current revenue growth of Kolmar Korea? | Kolmar Korea revenue growth (NTM/LTM) is 9%. |
| What is the current EV/Revenue multiple of Kolmar Korea? | Current revenue multiple of Kolmar Korea is 1.2x. |
| What is the current EBITDA of Kolmar Korea? | Kolmar Korea's last 12 months EBITDA is $263M. |
| What is Kolmar Korea's EBITDA margin? | Kolmar Korea's last 12 months EBITDA margin is 13%. |
| What is the current EV/EBITDA multiple of Kolmar Korea? | Current EBITDA multiple of Kolmar Korea is 9.0x. |
| What is the current FCF of Kolmar Korea? | Kolmar Korea's last 12 months FCF is $90M. |
| What is Kolmar Korea's FCF margin? | Kolmar Korea's last 12 months FCF margin is 5%. |
| What is the current EV/FCF multiple of Kolmar Korea? | Current FCF multiple of Kolmar Korea is 26.2x. |
| How many companies Kolmar Korea has acquired to date? | Kolmar Korea hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Kolmar Korea has invested to date? | As of July 2026, Kolmar Korea has invested in 1 company. |
| What was the last Kolmar Korea investment? | On 17th June 2026 Kolmar Korea invested in The SMC Group, participating in a $13M Undisclosed stage round, alongside Timepolio Asset Management, LB Investment, and Kolon Investment. |
| In what companies Kolmar Korea invested in? | Kolmar Korea invested in The SMC Group. |
See public comps similar to Kolmar Korea
Lists including Kolmar Korea
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.





